Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
681 Gateway Blvd., South San Francisco, California
State of incorporation
Delaware
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 553 % -14.7%
Quick Ratio 43.5 % -13.2%
Debt-to-equity 25.9 % +17.3%
Return On Equity -38.9 % -34.5%
Return On Assets -30.9 % -30.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.6M shares +2.07%
Common Stock, Shares, Outstanding 58.5M shares +2.01%
Entity Public Float 833M USD -65.1%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 58.1M shares +1.94%
Weighted Average Number of Shares Outstanding, Diluted 58.1M shares +1.94%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 176M USD +21.5%
Research and Development Expense 93.5M USD -17.1%
Costs and Expenses 530M USD +15.4%
Operating Income (Loss) -235M USD -4.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -220M USD -5.8%
Income Tax Expense (Benefit) 434K USD -74%
Net Income (Loss) Attributable to Parent -220M USD -5.17%
Earnings Per Share, Basic -3.82 USD/shares -2.97%
Earnings Per Share, Diluted -3.82 USD/shares -2.97%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 239M USD -22.2%
Cash, Cash Equivalents, and Short-term Investments 289M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 32M USD -24.9%
Inventory, Net 28.5M USD -21.6%
Assets, Current 362M USD -18.8%
Property, Plant and Equipment, Net 106M USD -24.5%
Operating Lease, Right-of-Use Asset 61.3M USD -14.9%
Goodwill 85.8M USD 0%
Other Assets, Noncurrent 5.22M USD -13.3%
Assets 638M USD -21.3%
Accounts Payable, Current 6.63M USD -45.6%
Employee-related Liabilities, Current 31.7M USD +16%
Accrued Liabilities, Current 14.8M USD +43.9%
Liabilities, Current 73.8M USD +1.28%
Operating Lease, Liability, Noncurrent 72.6M USD -9.11%
Other Liabilities, Noncurrent 597K USD +895%
Liabilities 147M USD -3.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -735K USD -15.7%
Retained Earnings (Accumulated Deficit) -1.21B USD -22.3%
Stockholders' Equity Attributable to Parent 491M USD -25.3%
Liabilities and Equity 638M USD -21.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23M USD +57.5%
Net Cash Provided by (Used in) Financing Activities -1.47M USD -273%
Net Cash Provided by (Used in) Investing Activities 4.17M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 58.5M shares +2.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2M USD +67%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 242M USD -22.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 302M USD +25.6%
Deferred Tax Assets, Gross 334M USD +21.9%
Operating Lease, Liability 87.2M USD -6.29%
Depreciation 7M USD +1.45%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -87.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -218M USD -3.01%
Lessee, Operating Lease, Liability, to be Paid 137M USD -8.16%
Property, Plant and Equipment, Gross 177M USD -5.08%
Operating Lease, Liability, Current 14.6M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.9M USD -4.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD +2.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 50M USD -11.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.37M USD -37.6%
Deferred Tax Assets, Operating Loss Carryforwards 209M USD +9.41%
Unrecognized Tax Benefits 19.2M USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.47M USD +4.61%
Operating Lease, Payments 14.4M USD 0%
Additional Paid in Capital 1.7B USD +3.29%
Amortization of Intangible Assets 5.2M USD -1.89%
Depreciation, Depletion and Amortization 8.17M USD +54.4%
Deferred Tax Assets, Net of Valuation Allowance 31.9M USD -5.02%
Share-based Payment Arrangement, Expense 50.3M USD +34.9%
Interest Expense 2K USD -92.9%